Charles River Financials
CRL Stock | USD 199.06 0.53 0.27% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Net Profit Margin | 0.12 | 0.11 |
|
| |||||
Return On Assets | 0.0604 | 0.0576 |
|
| |||||
Operating Income | 648.1 M | 617.3 M |
|
| |||||
Current Ratio | 1.99 | 1.52 |
|
|
Investors should never underestimate Charles River's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Charles River's cash flow, debt, and profitability to make informed and accurate decisions about investing in Charles River Laboratories.
Cash And Equivalents |
|
Charles | Select Account or Indicator |
Understanding current and past Charles River Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Charles River's financial statements are interrelated, with each one affecting the others. For example, an increase in Charles River's assets may result in an increase in income on the income statement.
Charles River Earnings Geography
Charles River Stock Summary
Charles River competes with ICON PLC, Mettler Toledo, Laboratory, Waters, and IDEXX Laboratories. Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts. Charles River operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 18600 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US1598641074 |
CUSIP | 159864107 |
Location | Massachusetts; U.S.A |
Business Address | 251 Ballardvale Street, |
Sector | Life Sciences Tools & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.criver.com |
Phone | 781 222 6000 |
Currency | USD - US Dollar |
Charles River Key Financial Ratios
Return On Equity | 0.12 | ||||
Profit Margin | 0.10 % | ||||
Operating Margin | 0.15 % | ||||
Price To Sales | 2.51 X | ||||
Revenue | 4.13 B |
Charles River Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.7B | 5.5B | 7.0B | 7.6B | 8.2B | 8.6B | |
Other Current Liab | 388.3M | 409.6M | 553.1M | 531.3M | 605.5M | 635.8M | |
Net Debt | 1.8B | 1.9B | 2.7B | 2.9B | 2.8B | 2.9B | |
Retained Earnings | 280.3M | 625.4M | 980.8M | 1.4B | 1.9B | 2.0B | |
Accounts Payable | 111.5M | 122.5M | 198.1M | 205.9M | 168.9M | 177.4M | |
Cash | 238.0M | 228.4M | 241.2M | 233.9M | 276.8M | 172.3M | |
Net Receivables | 514.0M | 617.7M | 642.9M | 752.4M | 780.4M | 819.4M | |
Inventory | 160.7M | 185.7M | 199.1M | 255.8M | 380.3M | 399.3M | |
Other Current Assets | 56.0M | 165.2M | 190.9M | 196.9M | 171.3M | 179.8M | |
Total Liab | 3.0B | 3.3B | 4.4B | 4.6B | 4.5B | 4.8B | |
Total Current Assets | 1.0B | 1.2B | 1.3B | 1.4B | 1.6B | 1.7B | |
Short Term Debt | 38.5M | 74.9M | 36.1M | 50.2M | 441.1M | 463.2M | |
Common Stock | 489K | 498K | 505K | 509K | 513K | 670.0K | |
Intangible Assets | 689.4M | 787.6M | 1.1B | 955.3M | 864.1M | 480.2M | |
Other Liab | 350.2M | 422.2M | 482.6M | 390.4M | 449.0M | 471.4M | |
Other Assets | 134.3M | 1.5B | (47.2M) | 1K | 1.2K | 1.1K | |
Long Term Debt | 1.8B | 1.9B | 2.6B | 2.7B | 2.6B | 2.8B | |
Good Will | 1.5B | 1.8B | 2.7B | 2.8B | 3.1B | 3.2B | |
Net Tangible Assets | (566.7M) | (456.7M) | (1.2B) | (786.5M) | (707.8M) | (672.4M) |
Charles River Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 60.9M | 86.4M | 73.9M | 59.3M | 136.7M | 143.5M | |
Total Revenue | 2.6B | 2.9B | 3.5B | 4.0B | 4.1B | 4.3B | |
Gross Profit | 958.3M | 1.1B | 1.3B | 1.5B | 1.5B | 1.6B | |
Operating Income | 351.2M | 432.7M | 589.9M | 651.0M | 617.3M | 648.1M | |
Ebit | 351.2M | 524.2M | 588.8M | 732.0M | 718.0M | 753.9M | |
Ebitda | 563.1M | 759.1M | 854.3M | 1.0B | 1.0B | 1.1B | |
Cost Of Revenue | 1.7B | 1.9B | 2.2B | 2.5B | 2.6B | 2.8B | |
Income Before Tax | 304.1M | 447.1M | 480.7M | 623.0M | 581.3M | 610.3M | |
Net Income | 252.0M | 364.3M | 391.0M | 486.2M | 474.6M | 498.4M | |
Income Tax Expense | 50.0M | 81.8M | 81.9M | 130.4M | 100.9M | 57.3M | |
Minority Interest | 2.0M | 1.0M | 7.9M | 6.4M | (5.6M) | (5.3M) | |
Tax Provision | 50.0M | 81.8M | 81.9M | 130.4M | 137.0M | 99.9M | |
Interest Income | 1.5M | 834K | 74.9M | 780K | 3.9M | 3.8M | |
Net Interest Income | (59.4M) | (85.6M) | (73.3M) | (58.5M) | (134.0M) | (127.3M) |
Charles River Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (21.4M) | (18.4M) | (25.2M) | (78.5M) | (62.3M) | (59.2M) | |
Change In Cash | 42.7M | (6.9M) | 13.2M | (5.1M) | 43.3M | 45.4M | |
Free Cash Flow | 340.4M | 380.0M | 532.0M | 294.9M | 365.4M | 192.8M | |
Depreciation | 198.1M | 234.9M | 265.5M | 303.9M | 314.1M | 329.8M | |
Other Non Cash Items | (12.8M) | (83.6M) | 6.0M | (62.0M) | (29.4M) | (27.9M) | |
Capital Expenditures | 140.5M | 166.6M | 228.8M | 324.7M | 318.5M | 334.5M | |
Net Income | 254.1M | 365.3M | 398.8M | 492.6M | 480.4M | 504.4M | |
End Period Cash Flow | 240.0M | 233.1M | 246.3M | 241.2M | 284.5M | 173.6M | |
Change To Netincome | 22.6M | 73.5M | 23.1M | (51.1M) | (46.0M) | (43.7M) | |
Investments | (21.4M) | (15.3M) | (39.0M) | (153.7M) | (280.4M) | (266.4M) | |
Change Receivables | (8.3M) | (85.6M) | (26.6M) | (150.6M) | (135.5M) | (128.7M) | |
Net Borrowings | 227.3M | 30.6M | 670.0M | 19.8M | 22.8M | 21.6M |
Charles Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Charles River's current stock value. Our valuation model uses many indicators to compare Charles River value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Charles River competition to find correlations between indicators driving Charles River's intrinsic value. More Info.Charles River Laboratories is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Charles River Laboratories is roughly 2.45 . At this time, Charles River's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Charles River by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Charles River Labora Systematic Risk
Charles River's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Charles River volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Charles River Labora correlated with the market. If Beta is less than 0 Charles River generally moves in the opposite direction as compared to the market. If Charles River Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Charles River Labora is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Charles River is generally in the same direction as the market. If Beta > 1 Charles River moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Charles River Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Charles River's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Charles River growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Charles River November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Charles River help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Charles River Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of Charles River Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing Charles Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Charles River's daily price indicators and compare them against related drivers.
Downside Deviation | 2.17 | |||
Information Ratio | (0.04) | |||
Maximum Drawdown | 18.19 | |||
Value At Risk | (4.35) | |||
Potential Upside | 2.82 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Earnings Share 8 | Revenue Per Share 78.97 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0487 |
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.